The development prospects of the traditional Chinese medicine market are broad, and the opportunity for pharmaceutical equipment companies is here!

[ Market analysis of chemical machinery equipment network ] In recent years, with the expansion of market demand and policy support, the development of the Chinese medicine industry has continued to accelerate.
According to statistics, the market size of Chinese medicinal materials in 2017 was 101.
8 billion yuan, reached nearly 124.
6 billion yuan in 2018, is expected to reach 170.
8 billion yuan in 2022, and exceed 200 billion yuan in 2024, with an average annual compound growth rate of nearly 10%.

 

But at the moment of the rapid development of the Chinese medicine industry, we also need to notice that the quality supervision of the Chinese medicine industry is becoming more and more stringent.
For example, the new Chinese Pharmacopoeia, which will be implemented in December this year, has strengthened the control of 33 prohibited pesticide residues in Chinese herbal medicines (prepared pieces), and improved the “Guiding Principles for the Establishment of Limits for Hazardous Residues in Traditional Chinese Medicines”, and established limits for various harmful substances.
Up the standard.
In addition, at present, all provinces across the country, especially the provinces with large Chinese medicinal materials production, have also successively issued relevant notices, clarifying that they will strengthen the quality management of Chinese medicinal materials and Chinese herbal medicines.

 

The industry believes that with the help of national policies, strict supervision and control of the Chinese medicine industry has become a general trend, and the quality of Chinese medicine will increasingly become a key issue affecting the development of pharmaceutical companies.
In fact, in the production of pharmaceuticals , pharmaceutical equipment is a key means to ensure the quality of pharmaceuticals.
Therefore, if pharmaceutical companies want to ensure drug safety, they cannot do without the help of pharmaceutical equipment.
As the quality requirements of traditional Chinese medicines continue to increase, how can pharmaceutical equipment companies help their compliance development while also ushering in their own development opportunities?
 

　　In this regard, industry insiders said that compliance is a prerequisite for the existence of products.
Therefore, relevant companies must first study domestic and foreign policies when producing pharmaceutical equipment, and then formulate their own product specifications based on the policies.
It is reported that a domestic equipment company focusing on environmental protection and energy saving equipment, with strong technical strength, superior product quality, high-standard quality assurance system and inherent technical content, can comply with the requirements of FDA, CGMP, and QS.
, We carefully design and manufacture high-quality equipment that meets various standards for customers.

 

　　In addition, its product specifications will exceed domestic standards.
"For example, the domestic GMP and Pharmacopoeia require conductivity to be 5.
1, and we will set the standard to <2.
Of course, the lower the conductivity, the requirements for equipment, such as design requirements, will be relatively The higher it is.
” said the relevant person.

 

　　Of course, in order to improve the quality of Chinese medicine, in addition to compliance, it is also important to promote the innovation and development of the Chinese medicine industry and to guide the construction of the information and intelligent manufacturing system of Chinese medicine.
At present, the level of technology and equipment in the Chinese medicine manufacturing industry needs to be improved urgently, and the technology has not been fully applied in the Chinese medicine manufacturing industry.
There are problems such as the on-line detection technology is not effectively integrated with the process and equipment, the process control level is not high, the automatic control technology DCS (distributed control system), PLC (programmable controller) adoption rate is low, and the equipment automation is not high.

 

　　Therefore, it is suggested in the industry to use the construction of a traditional Chinese medicine manufacturing mother factory as a carrier, to produce big data as a starting point, and to effectively combine intelligent pharmaceutical equipment with large-scale batch production to develop process technology intelligence and form a unique intelligent manufacturing capability.

 

　　It is understood that in order to meet the above needs, many pharmaceutical equipment companies in the industry are increasing the layout of smart factories.
The smart factory mainly includes three levels: lean production technology, excellent manufacturing technology, and digital platform.
Based on industrial Internet technology and big data analysis, smart factories can continuously improve product quality and comprehensive operating efficiency through the innovative R&D and application of a series of digital and intelligent tools, as well as the effective integration and optimization of material flow and information flow.

 

　　At present, Chutian has successfully launched the application of smart pharmaceutical engineering overall solutions in China, including vials, ampoules, oral liquid bottles, cartridge bottles, prefilled needles, three-in-one blow-filling, soft bags and large A series of fully automated production equipment and information management systems for the production of sterile medicines such as infusion glass bottles have created a digital and intelligent manufacturing factory through the deep integration of information technology and manufacturing technology.

 

　　In general, as people's consumption concepts change, there are also new demands for the quality of medicinal materials, which will force the Chinese medicine processing equipment industry to improve and innovate.
Especially since the beginning of this year, due to the impact of the special period, the market demand for Chinese herbal medicines and other products has expanded.
Traditionally outdated, low-capacity, and outdated equipment cannot meet production needs.
The equipment industry urgently needs to be improved and upgraded to increase production capacity.
Under the influence of the general environment, the industry predicts that automation, intelligence, and information will be the development trend of the traditional Chinese medicine equipment industry.
In the future, technological innovation may be set off.
At the same time, a large number of related pharmaceutical equipment companies may benefit.

 

　　Original title: The prospects for the development of the Chinese medicine market are broad, and the opportunities for pharmaceutical equipment companies are here!